Managers

Digital pathology startup Deep Lens rakes in $3.2 mln seed

Deep Lens Inc, a digital pathology startup, has secured $3.2 million in seed financing. Sierra Ventures led the round with participation from Rev1 Ventures and Tamarind Hill Fund. In conjunction with the financing, Mark Shary, managing member of Tamarind Hill, and Dr. Jeff Elton, CEO of Concerto Health AI, will join the Deep Lens board of directors.

Glilot raises $110 mlm for third fund

Glilot Capital Partners, an Israeli venture firm focused on early-stage startups, has closed its third fund at $110 million. As with the previous funds, Glilot III will invest in Israeli early-stage startups in artificial intelligence, big data and cyber security.

Larger deals fueling venture investing this year

East Coast LP Tiger Iron opens SF office, adds MP

NEA heads for close of innovative secondary process

Rhythm Venture Capital forms Rhythm Fund X

Rhythm Venture Capital has launched Rhythm Fund X, a new fund. Rhythm Fund X has raised an undisclosed amount of funding in its first closing. The fund is seeking to make its initial investment by the end of the first quarter of 2019. Rhythm Venture Capital focuses on digital health, healthcare services, biotech and life sciences.

Houston-based HX Venture Fund raises $25 mln

Houston Exponential has raised $25 million toward its Houston-based venture-capital fund of funds, the HX Venture Fund, according to a filing with the SEC.

VC-backed Allogene Therapeutics goes public

South San Francisco-based Allogene Therapeutics, a biotech company focused on cancer treatment, has raised $324 million after pricing its 18 million shares at $18 per share. The stock began trading October 11, 2018 on the NASDAQ under the ticker symbol "ALLO." Goldman Sachs, J.P. Morgan Securities LLC, Cowen and Company and Jefferies LLC are the lead underwriters. Allogene's pre-IPO backers included Vida Ventures.

Atomic Labs collects $148.4 mln for sophomore fund

Atomic Labs has raised $148.4 million for its second fund, according to an SEC filing. With offices in San Francisco, Phoenix and Ontario, the venture firm makes seed and early-stage investments.

Moonshots raises $20 mln for its inaugural fund

Moonshots Capital, a seed-stage venture firm founded by military veterans and serial entrepreneurs-turned VCs, announced it has raised $19 million for its inaugural fund. LPs include Dave McCormick, Co-CEO of Bridgewater Associates. The firm, led by Managing Partners Kelly Perdew and Craig Cummings, has offices in Los Angeles, California and Austin, Texas. Moonshots said it has already invested in four deals, including cybersecurity company New Knowledge and business travel booking provider Shep.